An immunocompromised BALB/c mouse model for respiratory syncytial virus infection

Virology Journal

Volumn 2, Issue , 2005, Pages

  Kong, Xiaoyuan ^a   Hellermann, Gary R ^a   Patton, Geoff ^a   Kumar, Mukesh ^a   Behera, Aruna ^a   Randall, Timothy S ^a   Zhang, Jian ^a   Lockey, Richard F ^a   Mohapatra, Shyam S ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; INFECTION RISK; INFECTION SENSITIVITY; LEUKOCYTE ACTIVATION; LUNG INFILTRATE; LUNG LAVAGE; LYMPHOCYTE MIGRATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SPECIES COMPARISON; VIRUS INFECTION;

ANIMALS; BODY WEIGHT; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER;

EID: 15544366161     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-2-3     Document Type: Article

References (31)

1. Behera AK, Kumar M, Matsuse H, Lockey RF, Mohapatra SS: Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 1998, 251(3):704-9.
2. Kumar M, Behera AK, Matsuse H, Lockey RF, Mohapatra SS: Intranasal IFN-gamma gene transfer protects BALB/c mice against respiratory syncytial virus infection. Vaccine 1999, 18(5-6):558-67.
3. Gollob JA, Veenstra KG, Mier JW, Atkins MB: Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12. J Immunother 2001, 24(1):91-8.
4. Le HN, Lee NC, Tsung K, Norton JA: Pre-existing tumor-sensitized T cells are essential for eradication of established tumors by IL-12 and cyclophosphamide plus IL-12. J Immunol 2001, 167(12):6765-72.
5. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW: Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 1997, 100(1):226-33.
6. Sobel DO, Ahvazi B, Jun HS, Chung YH, Yoon JW: Cyclophosphamide inhibits the development of diabetes in the diabetesprone BB rat. Diabetologia 2000, 43(8):986-94.
7. Arnold R, Werner F, Humbert B, Werchau H, Konig W: Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology 1994, 82(2):184-91.
8. Becker S, Quay J, Soukup J: Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virusinfected human alveolar macrophages. J Immunol 1991, 147(12):4307-12.
9. Behera AK, Matsuse H, Kumar M, Kong X, Lockey RF, Mohapatra SS: Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection. Biochem Biophys Res Commun 2001, 280(1):188-95.
10. Bitko V, Velazquez A, Yang L, Yang YC, Barik S: Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. Virology 1997, 232(2):369-78.
11. Elias JA, Zheng T, Einarsson O, Landry M, Trow T, Rebert N, Panuska J: Epithelial interleukin-11. Regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem 1994, 269(35):22261-8.
12. Garofalo R, Mei F, Espejo R, Ye G, Haeberle H, Baron S, Ogra PL, Reyes VE: Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol 1996, 157(6):2506-13.
13. Noah TL, Becker S: Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 1993, 265(5 Pt 1):L472-8.
14. Bonville CA, Rosenberg HF, Domachowske JB: Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol 1999, 10(1):39-44.
15. Hornsleth A, Loland L, Larsen LB: Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J Clin Virol 2001, 21(2):163-70.
16. Noah TL, Becker S: Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol 2000, 97(1):43-9.
17. Saito T, Deskin RW, Casola A, Haeberle H, Olszewska B, Ernst PB, Alam R, Ogra PL, Garofalo R: Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 1997, 175(3):497-504.
18. Aberle JH, Aberle SW, Dworzak MN, Mandl CW, Rebhandl W, Vollnhofer G, Kundi M, Popow-Kraupp T: Reduced interferongamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med 1999, 160(4):1263-8.
19. Byrd LG, Prince GA: Animal models of respiratory syncytial virus infection. Clin Infect Dis 1997, 25(6):1363-8.
20. Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS: The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 2002, 168(6):2944-52.
21. Lukacs NW, Tekkanat KK, Berlin A, Hogaboam CM, Miller A, Evanoff H, Lincoln P, Maassab H: Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001, 167(2):1060-5.
22. Matsuse H, Behera AK, Kumar M, Lockey RF, Mohapatra SS: Differential cytokine mRNA expression in Dermatophagoides farinae allergen-sensitized and respiratory syncytial virusinfected mice. Microbes Infect 2000, 2(7):753-9.
23. Ruan Y, Okamoto Y, Matsuzaki Z, Endo S, Matsuoka T, Kohno T, Chazono H, Eiko I, Tsubota K, Saito I: Suppressive effect of locally produced interleukin-10 on respiratory syncytial virus infection. Immunology 2001, 104(3):355-60.
24. Tekkanat KK, Maassab HF, Cho DS, Lai JJ, John A, Berlin A, Kaplan MH, Lukacs NW: IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J Immunol 2001, 166(5):3542-8.
25. Graham BS, Perkins MD, Wright PF, Karzon DT: Primary respiratory syncytial virus infection in mice. J Med Virol 1988, 26(2):153-62.
26. Sudo K, Watanabe W, Mori S, Konno K, Shigeta S, Yokota T: Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo. Antivir Chem Chemother 1999, 10(3):135-9.
27. Stark JM, McDowell SA, Koenigsknecht V, Prows DR, Leikauf JE, Le Vine AM, Leikauf GD: Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J Med Virol 2002, 67(1):92-100.
28. Sudo K, Watanabe W, Konno K, Sato R, Kajiyashiki T, Shigeta S, Yokota T: Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice. Antimicrob Agents Chemother 1999, 43(4):752-7.
29. Matsuse H, Behera AK, Kumar M, Rabb H, Lockey RF, Mohapatra SS: Recurrent respiratory syncytial virus infections in allergensensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol 2000, 164(12):6583-92.
30. Sweet MJ, Stacey KJ, Kakuda DK, Markovich D, Hume DA: IFNgamma primes macrophage responses to bacterial DNA. J Interferon Cytokine Res 1998, 18(4):263-71.
31. Behera AK, Kumar M, Lockey RF, Mohapatra SS: 2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J Biol Chem 2002, 227:25601-25608.